Atlas Trials

A Study of ADH 1 in Combination With Carboplatin, or Docetaxel or Capecitabine

Clinical trial NCT00390676 · COMPLETED

Trial details

NCT number
NCT00390676
Sponsor
Adherex Technologies, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Neoplasms
Start date
2006-11-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.